Results 201 to 210 of about 48,974 (212)

Separation of plasma-derived exosomes into CD3(+) and CD3(−) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients

Clinical and Experimental Immunology, 2018
Theresa L. Whiteside, T K Hoffmann
exaly  

EGFR Inhibitors and Radiation in HNSCC

Current Cancer Therapy Reviews, 2007
Laura Chow, Changhu Chen, David Raben
openaire   +1 more source

Analysis of exosomal miRNA in HNSCC in the blood – Possible liquid biomarkers for HPV+HNSCC?

Laryngo-Rhino-Otologie
Maximilian Oberste, Carla Apeltrath, Armands Riders, Claudia Rudack, Frank Simon   +4 more
openaire   +1 more source

DIAGNOSIS OF METASTASES IN HNSCC TUMOURS

2006
HOLSTEGE FRANK CHARLES PATRICK, SLOOTWEG PIETER JOHANNES, ROEPMAN PAUL   +2 more
openaire   +2 more sources

EGFR inhibition for recurrent or metastatic HNSCC

The Lancet Oncology, 2015
openaire   +2 more sources

Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC

EBioMedicine, 2019
Cameron Fletcher, Qi Zhao, Dongsheng Zhang   +2 more
exaly  

Hypofolatemia in HNSCC: Epidemiology and Chemoprevention

Otolaryngology–Head and Neck Surgery, 2010
Giovanni Almadori, Francesco Bussu, Silvia Persichilli, Gaetano Paludetti   +3 more
openaire   +1 more source

Success of Salvage Treatment: A Critical Appraisal of Salvage Rates for Different Subsites of HNSCC

Otolaryngology - Head and Neck Surgery, 2014
Thomas Pézier, Gerhard F Huber, Nicole Graf   +2 more
exaly  

Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy*

Journal of Biological Chemistry, 2016
Cun-Yu Wang
exaly  

Individualized Prognosis in Recurrent HNSCC

2012
openaire   +1 more source